San Diego, CA – According to filings with the U.S. Securities and Exchange Commission, BioFluidica is raising $9,999,999.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Rolf Muller played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About BioFluidica
BioFluidica is a biotechnology company dedicated to eliminating obstacles to the adoption of liquid biopsy as a tool for researchers and clinicians. Our strategy combines cutting-edge microfluidics, advanced immunoaffinity chemistries, automation hardware, and workflow optimizations to improve sensitivity and specificity, increase throughput, and enable the isolation and enrichment of multiple disease biomarkers from a single sample.

To learn more about BioFluidica, visit http://www.biofluidica.com/

Contact:
Rolf Muller, Chief Executive Officer
858-535-6493
rmuller@biofluidica.com
https://www.linkedin.com/in/rolf-muller-4344263/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved